Registered outcomes12

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 12 of 12

List	Outcome	Time frame	Description
Primary	ALT	Pre Treatment (mean)	Alanine transaminase
Primary	ALT	Months 1,2,3,6,9,12 (mean)	Alanine transaminase
Primary	Cu Serum	Pre Treatment (mean)
Primary	Cu Serum	Months 1,2,3,6,9,12 (mean)
Secondary	INR	Pre Treatment (mean)	The International Normalized Ratio (INR) is a standard way to describe the time it takes for blood to clot; an INR range of 0.8 to 1.2 is considered normal for a healthy person who is not using oral anticoagulant therapy
Secondary	INR	Months 1,2,3,6,9,12 (mean)	The International Normalized Ratio (INR) is a standard way to describe the time it takes for blood to clot; an INR range of 0.8 to 1.2 is considered normal for a healthy person who is not using oral anticoagulant therapy
Secondary	Albumin	Pre Treatment (mean)
Secondary	Albumin	Months 1,2,3,6,9,12 (mean)
Secondary	Cu Urine	Pre Treatment (mean)
Secondary	Cu Urine	Months 1,2,3,6,9,12 (mean)
Secondary	Zn Urine	Pre Treatment (mean)
Secondary	Zn Urine	Months 1,2,3,6,9,12 (mean)

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01472874/registered